加载中
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
收盘时
US$3.39
+US$0.07 · +2.11%
盘后
US$3.39
US$0.00 · 0.00%
10月13日 16:00 ET
盘中时间采用ET。市场数据可能有所延迟。
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
日内区间
当前US$3.39
52周区间
当前US$3.39
盘中时间采用ET。市场数据可能有所延迟。
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
日内区间
当前US$3.39
52周区间
当前US$3.39
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 117.42万 USD | 1564.94万 USD | — | — | 38.32万 USD |
| 销货成本 | 66.3万 USD | 66.29万 USD | 66.3万 USD | 67.15万 USD | 1599.9万 USD |
| 毛利 | 51.12万 USD | 1498.66万 USD | −66.3万 USD | −67.15万 USD | −997.89万 USD |
| 研究与开发 | 35.45亿 USD | 900.51万 USD | 1409.94万 USD | 1967.43万 USD | 2325.25万 USD |
| 销售、一般及管理费用 | 74.39亿 USD | 777.34万 USD | 847.46万 USD | 1341.24万 USD | 768.8万 USD |
| 营业费用 | 1032.17万 USD | 1611.56万 USD | 1789.24万 USD | 3308.67万 USD | 2374.37万 USD |
| 利息收入 | 66.56万 USD | 16.65万 USD | 22.01万 USD | 48.64万 USD | 9867 USD |
| 利息支出 | — | — | — | — | 2.69万 USD |
| 折旧和摊销 | 66.3万 USD | 66.29万 USD | 66.3万 USD | 97.07万 USD | 110.99万 USD |
| 营业利润 | −981.05万 USD | −112.91万 USD | −2678.67万 USD | −3308.67万 USD | −3101.72万 USD |
| 净利润 | −1345.19万 USD | −36.96万 USD | −1549.22万 USD | −3218.17万 USD | −2293.92万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2024年12月24日 | 1:12 | — | — |
已生效 2024年12月24日
1:12
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
